PSTX
Poseida Therapeutics Inc
$2.07
Earnings Summary
Revenue | $25Mn |
Net Profits | $-23.99Mn |
Net Profit Margins | -95.98% |
Highlights
Poseida Therapeutics Inc’s revenue jumped 151.95% since last year same period to $25Mn in the Q4 2023. On a quarterly growth basis, Poseida Therapeutics Inc has generated 167.27% jump in its revenue since last 3-months.
Poseida Therapeutics Inc’s net profit jumped 28% since last year same period to $-23.99Mn in the Q4 2023. On a quarterly growth basis, Poseida Therapeutics Inc has generated 24.51% jump in its net profits since last 3-months.
Poseida Therapeutics Inc’s net profit margin jumped 71.42% since last year same period to -95.98% in the Q4 2023. On a quarterly growth basis, Poseida Therapeutics Inc has generated 71.75% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Poseida Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.42 |
EPS Estimate Current Year | -0.42 |
Highlights
Poseida Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.42 - a -7.69% fall from last quarter’s estimates.
Poseida Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.42.
Key Ratios
Key ratios of the Poseida Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.27 |
Highlights
Poseida Therapeutics Inc’s earning per share (EPS) jumped 30.77% since last year same period to -0.27 in the Q4 2023. This indicates that the Poseida Therapeutics Inc has generated 30.77% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-09 | -0.29 | -0.35 | -20.69% |
2024-03-07 | -0.39 | -0.27 | 30.77% |
2023-05-09 | -0.45 | -0.45 | 0% |
2023-08-08 | -0.53 | -0.32 | 39.62% |
₹0 US Stocks a/c Opening Fee